XML 43 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONVERTIBLE NOTES AND DERIVATIVE LIABILITY (Tables)
12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Schedule of convertible notes
     
Balance, December 31, 2021  $943,017 
Proceeds received   912,952 
Value of convertible notes converted to 97,646,062 common shares   (552,517)
Note discount   (162,392)
Balance, net of note discount, December 31, 2022   1,141,060 
Proceeds received   439,501 
Value of conversion of notes to 166,607,680 common shares   (222,096)
Note discount   162,393 
Balance, December 31, 2023  $1,520,858 
Schedule of convertible notes outstanding
       
Maturity Date Interest Rate Conversion price

Principal at

inception

Principal

outstanding

      $ $
Jan. 7, 2021 8% 75% of the lowest 20-day share price before the conversion date 100,000 100,000
Dec. 11, 2022 24% Lowest of the 60-day share price before the conversion date 312,500 312,500
Nov. 1, 2023 10% 50% of lowest 20-day share price before the conversion date 35,000 38,534
Nov. 3, 2023 10% 61% of the lowest 20-day share price before the conversion date 54,250 17,321
Dec. 13, 2023 10% 61% of lowest 20-day share price before the conversion date 53,750 53,750
Jan. 28, 2024 10% 61% of lowest 20-day share price before the conversion date 43,750 43,750
Feb. 06, 2024 10% 61% of lowest 20-day share price before the conversion date 55,000 55,000
Mar. 28, 2024 10% 61% of lowest 20-day share price before the conversion date 55,000 55,000
May 5, 2024 12% Lesser of $0.0025 or 70% of lowest 5-day share price before the conversion date 60,000 60,000
      769,250 735,855
Schedule of assumption used for derivative liabilities
     
   2023 
Stock Price  $0.002 
Exercise Price  $0.001 
Risk-free interest rate   3.91% 
Expected volatility   240.65% 
Expected life   1.00 years 
Expected dividend yield   0.00%